Vanda Pharmaceuticals Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
ARS/A
CORRESP
CT ORDER
DEF 14A
DEFA14A
DFAN14A
EFFECT
PREC14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002588 | Mar 27, 2026 | — |
| 8-K | 8-K | 0001628280-26-016516 | Mar 10, 2026 | — |
| 4 | 4 | 0001748392-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001806596-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001785888-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001355537-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001702031-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 144 | — | 0001193125-26-086369 | Mar 2, 2026 | — |
| 144 | — | 0001193125-26-086349 | Mar 2, 2026 | — |
| 144 | — | 0001193125-26-086325 | Mar 2, 2026 | — |
| 144 | — | 0001193125-26-086321 | Mar 2, 2026 | — |
| 144 | — | 0001193125-26-086301 | Mar 2, 2026 | — |
| 4 | 4 | 0001193125-26-067185 | Feb 24, 2026 | Feb 23, 2026 |
| 144 | — | 0001193125-26-064742 | Feb 23, 2026 | — |
| 8-K | 8-K | 0001628280-26-010376 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-059792 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059784 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059781 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059778 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059770 | Feb 19, 2026 | Feb 18, 2026 |
| 8-K | 8-K | 0001628280-26-009805 | Feb 19, 2026 | Feb 18, 2026 |
| S-3 | S-3 | 0001628280-26-007476 | Feb 12, 2026 | — |
| 10-K | 10-K | 0001628280-26-007460 | Feb 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-007256 | Feb 11, 2026 | — |
| SCHEDULE 13G/A | — | 0002052113-26-000212 | Jan 21, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-002483 | Jan 9, 2026 | — |
| 8-K | 8-K | 0001628280-26-001273 | Jan 8, 2026 | Jan 7, 2026 |
| 8-K | 8-K | 0001628280-25-059155 | Dec 31, 2025 | Dec 30, 2025 |
| 8-K | 8-K | 0001628280-25-055393 | Dec 4, 2025 | — |
| 8-K | 8-K | 0001628280-25-054225 | Nov 28, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-047317 | Oct 30, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-047112 | Oct 29, 2025 | — |
| 8-K | 8-K | 0001628280-25-043489 | Oct 1, 2025 | — |
| 4 | 4 | 0000950170-25-105819 | Aug 8, 2025 | Aug 7, 2025 |
| 10-Q | 10-Q | 0001628280-25-036861 | Jul 31, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001628280-25-036843 | Jul 31, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-064754 | Jul 1, 2025 | — |
| 4 | 4 | 0000950170-25-087025 | Jun 16, 2025 | Jun 13, 2025 |
| 144 | — | 0000950170-25-086506 | Jun 13, 2025 | — |
| 4 | 4 | 0000950170-25-083890 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083889 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083888 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083885 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083884 | Jun 9, 2025 | Jun 5, 2025 |
| S-8 | S-8 | 0001628280-25-029697 | Jun 5, 2025 | — |
| 8-K | 8-K | 0001628280-25-029678 | Jun 5, 2025 | — |
| DEFA14A | DEFA14A | 0001628280-25-027698 | May 27, 2025 | — |
| 4 | 4 | 0000950170-25-076012 | May 21, 2025 | — |
| 4 | 4 | 0000950170-25-074565 | May 19, 2025 | May 16, 2025 |
| 10-Q | 10-Q | 0001628280-25-023448 | May 8, 2025 | Mar 31, 2025 |